STOCK TITAN

Earth Science Tech, Inc. Reports Fiscal Year-End Results for March 31, 2025, with Revenue Exceeding $33.1 Million and Net Profit of $3.2 Million

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Earth Science Tech (OTC: ETST) has reported exceptional financial results for the fiscal year ended March 31, 2025. The company achieved significant growth across all key metrics, with revenue reaching $33.1 million, representing a remarkable 177.05% increase year-over-year.

The company's performance showed substantial improvements in profitability, with net profit surging by 300.63% to $3.2 million. Cash position strengthened by 111.15% to $1.47 million, while total assets grew by 82.07% to $7.07 million. Additionally, ETST reduced its outstanding shares by 4.72%, demonstrating commitment to shareholder value.

Earth Science Tech (OTC: ETST) ha riportato risultati finanziari eccezionali per l'anno fiscale conclusosi il 31 marzo 2025. L'azienda ha registrato una crescita significativa in tutti i principali indicatori, con ricavi che hanno raggiunto 33,1 milioni di dollari, segnando un notevole aumento del 177,05% rispetto all'anno precedente.

Le performance della società hanno mostrato miglioramenti sostanziali nella redditività, con un utile netto in crescita del 300,63% fino a 3,2 milioni di dollari. La posizione di cassa si è rafforzata del 111,15%, arrivando a 1,47 milioni di dollari, mentre il totale degli attivi è aumentato dell'82,07%, raggiungendo 7,07 milioni di dollari. Inoltre, ETST ha ridotto le azioni in circolazione del 4,72%, dimostrando un impegno concreto verso il valore per gli azionisti.

Earth Science Tech (OTC: ETST) ha reportado resultados financieros excepcionales para el año fiscal finalizado el 31 de marzo de 2025. La compañía logró un crecimiento significativo en todos los indicadores clave, con ingresos que alcanzaron los 33,1 millones de dólares, lo que representa un notable aumento del 177,05% interanual.

El desempeño de la empresa mostró mejoras sustanciales en la rentabilidad, con un beneficio neto que se disparó un 300,63% hasta los 3,2 millones de dólares. La posición de efectivo se fortaleció un 111,15%, llegando a 1,47 millones de dólares, mientras que los activos totales crecieron un 82,07% hasta 7,07 millones de dólares. Además, ETST redujo sus acciones en circulación en un 4,72%, demostrando su compromiso con el valor para los accionistas.

Earth Science Tech (OTC: ETST)는 2025년 3월 31일로 종료된 회계연도에 대해 뛰어난 재무 성과를 보고했습니다. 회사는 모든 주요 지표에서 상당한 성장을 이루었으며, 매출은 3,310만 달러에 달해 전년 대비 177.05%라는 놀라운 증가율을 기록했습니다.

회사의 실적은 수익성에서 큰 개선을 보였으며, 순이익은 300.63% 증가하여 320만 달러에 달했습니다. 현금 보유액은 111.15% 증가하여 147만 달러가 되었고, 총 자산은 82.07% 증가하여 707만 달러에 이르렀습니다. 또한 ETST는 유통 주식을 4.72% 줄여 주주 가치에 대한 의지를 보여주었습니다.

Earth Science Tech (OTC : ETST) a annoncé des résultats financiers exceptionnels pour l'exercice clos le 31 mars 2025. L'entreprise a enregistré une croissance significative sur tous les indicateurs clés, avec un chiffre d'affaires atteignant 33,1 millions de dollars, soit une augmentation remarquable de 177,05% par rapport à l'année précédente.

La performance de la société a montré des améliorations substantielles en matière de rentabilité, avec un bénéfice net en hausse de 300,63% atteignant 3,2 millions de dollars. La trésorerie s'est renforcée de 111,15% pour atteindre 1,47 million de dollars, tandis que le total des actifs a augmenté de 82,07% pour s'établir à 7,07 millions de dollars. De plus, ETST a réduit ses actions en circulation de 4,72%, démontrant ainsi son engagement envers la création de valeur pour les actionnaires.

Earth Science Tech (OTC: ETST) hat außergewöhnliche Finanzergebnisse für das am 31. März 2025 endende Geschäftsjahr gemeldet. Das Unternehmen verzeichnete ein signifikantes Wachstum in allen wichtigen Kennzahlen, wobei der Umsatz 33,1 Millionen US-Dollar erreichte, was einer bemerkenswerten Steigerung von 177,05% im Jahresvergleich entspricht.

Die Leistung des Unternehmens zeigte erhebliche Verbesserungen in der Rentabilität, mit einem Nettogewinn, der um 300,63% auf 3,2 Millionen US-Dollar anstieg. Die Liquiditätsposition verbesserte sich um 111,15% auf 1,47 Millionen US-Dollar, während die Gesamtvermögenswerte um 82,07% auf 7,07 Millionen US-Dollar wuchsen. Darüber hinaus reduzierte ETST seine ausstehenden Aktien um 4,72%, was das Engagement für den Aktionärswert unterstreicht.

Positive
  • Revenue surged by 177.05% year-over-year to $33.1 million
  • Net profit increased by 300.63% to $3.2 million
  • Gross profit grew by 210.41% to $24.3 million
  • Cash position improved by 111.15% to $1.47 million
  • Total assets increased by 82.07% to $7.07 million
  • Outstanding shares reduced by 4.72%, indicating less dilution
Negative
  • None.

Miami, FL, June 26, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses, today shares its financial results for the year ended March 31, 2025.

For the fiscal year ended March 31, 2025, the Company reported the following results:

  • Cash: $1,473,228, compared to $697,721 as of March 31, 2024—an increase of $775,507, representing a 111.15% year-over-year improvement.

  • Total Assets: $7,066,721, compared to $3,881,336 as of March 31, 2024—an increase of $3,185,385, representing an 82.07% year-over-year improvement.

  • Revenue: $33,117,624, compared to $11,953,635 for the year ended March 31, 2024—an increase of $21,163,989, representing a 177.05% year-over-year improvement.

  • Gross Profit: $24,300,136, compared to $7,828,496 for the year ended March 31, 2024—an increase of $16,471,640, representing a 210.41% year-over-year improvement.

  • Net Profit: $3,253,635, compared to $812,139 for the year ended March 31, 2024—an increase of $2,441,496, representing a 300.63% year-over-year improvement.

  • Outstanding Shares: 295,347,903 shares of common stock issued and outstanding, compared to 309,981,819 shares as of March 31, 2024—a reduction of 14,633,916 shares, representing a 4.72% decrease in shares outstanding.

About Earth Science Tech, Inc.

Earth Science Tech, Inc. operates as a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The Company’s current operations include compounding pharmaceuticals, telemedicine and real estate development through its wholly owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC (“Mister Meds”), and Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC., and an 80% interest in MagneChef.

To learn more, please visit: www.EarthScienceTech.com

RxCompoundStore.com, LLC.

RxCompoundStore.Com, based in Miami, Florida, is a fully licensed compounding pharmacy authorized to fulfill prescriptions in the following states and territories: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Maine, Maryland, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Utah, Wisconsin and Puerto Rico. RxCompound is actively pursuing licensure in the remaining U.S. states.

To learn more please visit: www.RxCompoundStore.com

MisterMeds, LLC.

Mister Meds, acquired on October 1, 2024, is in Abilene, Texas. The pharmacy received full compounding licensure in March 2025. It operates out of a 5,000 sq. ft. facility owned by Avenvi and includes advanced sterile compounding capabilities with both positive and negative pressure environments, as well as hazardous drug handling. Mister Meds is currently applying for licensure in states not yet serviced by RxCompound.

To learn more please visit: www.mistermeds.com

Peaks Curative, LLC.

Peaks is a telemedicine referral platform offering asynchronous consultations for Peaks-branded compounded medications prepared at RxCompound and Mister Meds. The platform operates in states where either pharmacy is licensed. Through the development of its own healthcare provider network, MyOnlineConsultation.com, and ongoing licensure expansion for both pharmacies, Peaks aims to offer services nationwide. In addition, the company has recently expanded into the veterinary market through the acquisition of Zoolzy.com.

To learn more please visit: www.PeaksCurative.com

Las Villas Health Care, Inc.

Las Villas is a brick-and-mortar healthcare facility dedicated to the Spanish speaking community. Our expert-led services include advanced sexual health treatments, and customized solutions to enhance physical performance. We combine compassionate, personalized care with clear, trustworthy education—empowering you to take control of your health with confidence.

To learn more please visit: https://villashealth.com

Doconsultation.com, LLC.

Doconsultation was born with a passion to modernize the availability and delivery of home therapies. DOConsultations providers tailor a medication plan around your health and wellness goals and follow up with our patients to ensure results, while our partner pharmacies conveniently ship directly to your door.

To learn more please visit: https://doconsultations.com/

Avenvi, LLC.

Avenvi is a diversified real estate company engaged in development, asset management, and financing. With a growing portfolio of real estate holdings, Avenvi provides turnkey solutions from development to end-user financing. It also manages investment activities for ETST and oversees the Company’s ongoing $5 million share repurchase program.

To learn more please visit: www.avenvi.com

MagneChef

MagneChef is a direct-to-consumer retail brand. Utilizing its patents and intellectual properties, the company aims to develop new products that can be marketed and sold online. Currently, the company has developed products for cooking. MagneChef is in the process of expanding its product line for new offerings that incorporate its intellectual property.

To learn more please visit: https://magnechef.com/

About Earth Science Foundation, Inc.

Earth Science Foundation Inc. a 501(c)(3) nonprofit organization incorporated on February 11, 2019, is the charitable arm of ETST. ESF accepts grants and donations to assist individuals who need financial support for prescription costs at both RxCompound and Mister Meds.

SAFE HARBOR ACT: Forward-Looking Statements. Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Company Contact:
Giorgio R. Saumat
CEO and Chairman of the Board
(305) 724-5684
IR@earthsciencetech.com


FAQ

What was Earth Science Tech's (ETST) revenue for fiscal year 2025?

ETST reported revenue of $33.1 million for the fiscal year ended March 31, 2025, representing a 177.05% increase from the previous year's $11.95 million.

How much profit did ETST generate in fiscal year 2025?

ETST generated a net profit of $3.25 million for fiscal year 2025, showing a substantial 300.63% increase from $812,139 in the previous year.

What was ETST's cash position as of March 31, 2025?

ETST reported a cash position of $1.47 million as of March 31, 2025, up 111.15% from $697,721 in the previous year.

How did ETST's share count change in fiscal year 2025?

ETST reduced its outstanding shares by 4.72%, from 309,981,819 to 295,347,903 shares, demonstrating a commitment to reducing share dilution.

What was Earth Science Tech's gross profit margin for fiscal year 2025?

ETST achieved a gross profit of $24.3 million on revenue of $33.1 million, representing a gross profit margin of approximately 73.4%.
Earth Science Te

OTC:ETST

ETST Rankings

ETST Latest News

ETST Stock Data

37.17M
101.61M
66.06%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Miami